Ovid Therapeutics (OVID) Net Shares Issued and Repurchased (2016 - 2022)

Ovid Therapeutics (OVID) has reported Net Shares Issued and Repurchased for 7 consecutive years, with $2.4 million the latest figure, recorded in Q1 2022.

• For the quarter ending Q1 2022, Net Shares Issued and Repurchased rose 277.06% year-over-year to $2.4 million; the trailing twelve-month figure through Mar 2022 stood at $2.4 million (up 277.06% YoY), and the FY2021 full-year result was $2.0 million, down 42.9% from the prior year.
• Net Shares Issued and Repurchased improved to $2.4 million in Q1 2022 per OVID's latest filing, from $2.0 million in the prior quarter.
• Across five years, Net Shares Issued and Repurchased topped out at $3.6 million in Q4 2020 and bottomed at $530300.0 in Q1 2020.
• Historically, Net Shares Issued and Repurchased has averaged $1.9 million across 5 years, with a median of $1.5 million in 2019.
• The sharpest annual moves came in 2020 and 2022: Net Shares Issued and Repurchased plunged 63.65% in 2020, then jumped 277.06% in 2022.
• Over 5 years, Net Shares Issued and Repurchased stood at $1.4 million in 2018, then soared by 146.26% to $3.5 million in 2019, then increased by 1.0% to $3.6 million in 2020, then sank by 42.9% to $2.0 million in 2021, then gained by 18.61% to $2.4 million in 2022.
• According to Business Quant data, Net Shares Issued and Repurchased over the past three periods registered $2.4 million, $2.0 million, and $643600.0 for Q1 2022, Q4 2021, and Q1 2021 respectively.